Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HAE”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04180163
What this trial is testing

Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 12
Large-scale testing (Phase 3)Study completedNCT03485911
What this trial is testing

Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE

Who this might be right for
Hereditary AngioedemaHAE
BioCryst Pharmaceuticals 121
Testing effectiveness (Phase 2)Study completedNCT00949182
What this trial is testing

Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Rutgers, The State University of New Jersey 20
Testing effectiveness (Phase 2)Study completedNCT05695248
What this trial is testing

Navenibart (STAR-0215) in Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Astria Therapeutics, Inc. 29
Not applicableUnknownNCT02159430
What this trial is testing

Hereditary AngioEdema, Neurobiology and Psychopathology

Who this might be right for
Hereditary AngioEdemaAnxietyDepression
University Hospital, Catania 35
Large-scale testing (Phase 3)Study completedNCT00456508
What this trial is testing

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 147
Large-scale testing (Phase 3)Study completedNCT00997204
What this trial is testing

EASSI - Evaluation of the Safety of Self-Administration With Icatibant

Who this might be right for
Hereditary Angioedema
Shire 151
Large-scale testing (Phase 3)Study completedNCT00438815
What this trial is testing

Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 113
Testing effectiveness (Phase 2)Study completedNCT01095497
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration

Who this might be right for
Hereditary Angioedema
Shire 26
Not applicableNot Yet RecruitingNCT05833620
What this trial is testing

Identification and Characterization of Genetic Variants in Hereditary Angioedema

Who this might be right for
Hereditary Angioedema With C1 Esterase Inhibitor Deficiency
Hospital Universitari Vall d'Hebron Research Institute 200
Large-scale testing (Phase 3)Study completedNCT05259917
What this trial is testing

A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 136
Not applicableApproved For MarketingNCT04428632
What this trial is testing

Oral Berotralstat Expanded Access Program

Who this might be right for
Hereditary AngioedemaHAEProphylaxis
BioCryst Pharmaceuticals
Not applicableNot Yet RecruitingNCT06811467
What this trial is testing

Suicide Ideation in Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)Suicidal IdeationCardiovascular Risk
Ivan Cherrez Ojeda 100
Large-scale testing (Phase 3)Study completedNCT02052141
What this trial is testing

Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 12
Large-scale testing (Phase 3)Study completedNCT01005888
What this trial is testing

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 26
Large-scale testing (Phase 3)Study completedNCT04656418
What this trial is testing

CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks

Who this might be right for
Hereditary Angioedema
CSL Behring 64
Post-approval studies (Phase 4)WithdrawnNCT01151735
What this trial is testing

C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation

Who this might be right for
Hereditary Angioedema
Penn State University
Not applicableNot Yet RecruitingNCT07445087
What this trial is testing

Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 35
Large-scale testing (Phase 3)Enrolling By InvitationNCT04933721
What this trial is testing

Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies

Who this might be right for
Hereditary AngioedemaHAE
BioCryst Pharmaceuticals 139
Not applicableStudy completedNCT06587464
What this trial is testing

Explore Hereditary Angioedema (HAE) Symptoms and Treatment Patterns in Korean People

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 19
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation